Kolexia
Megret-Loiseau Pascale Médecine générale
Megret-Loiseau Pascale
Médecine générale
Hôpital Saint-Louis
Paris, France
66 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie du greffon contre l'hôte Purpura thrombotique thrombocytopénique Purpura Tumeurs hématologiques Purpura thrombopénique Prédisposition génétique à une maladie Maladie aigüe Anémie Leucémies

Collaborateurs

Voir plus
Socie Gerard
Socie Gerard
Hôpital Saint-Louis, Paris, France
Yakoub-Agha Ibrahim
Yakoub-Agha Ibrahim
Centre Hospitalier de Lille, Lille, France
Peffault De Latour Regis
Peffault De Latour Regis
Hôpital Saint-Louis, Paris, France
Dubois Valerie
Dubois Valerie
Efs Aura - Siege Regional, Décines-Charpieu, France

Industries

Voir plus
Keocyt
1 collaboration(s)
Dernière en 2017
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
HLA-DRB1*11 is a strong risk factor for acquired thrombotic thrombocytopenic purpura in children.
Haematologica   01 octobre 2020
HLA-Matched Unrelated Donors for Patients with Sickle Cell Disease: Results of International Donor Searches.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation   23 juillet 2020
Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus-host disease in conjunction with the CMV status.
Bone marrow transplantation   14 avril 2020
SPIRIT: A Phase III Prospective Randomized Comparison of Imatinib at a Dose of 400mg in Combination With Peg-Interferon-alpha2a (Peg-IFNa2a) or Cytarabine (Ara-C)Versus Imatinib at a Dose of 600mg Versus Imatinib a Dose of 400mg for Previously Untreated Chronic Myelogenous Leukemia (CML) in Chronic Phase
Essai Clinique (Novartis)   10 avril 2020
Human Leukocyte Antigen Matched Unrelated Donors for Patients with Sickle Cell Disease According to Geographic Origin: Results of International Donor Searches
Blood   13 novembre 2019
Haploidentical hematopoietic stem cell transplant: How to choose the best donor? Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
Bulletin du cancer   02 octobre 2019
Recovery of central memory and naive peripheral T cells in Follicular Lymphoma patients receiving rituximab-chemotherapy based regimen.
Scientific reports   17 septembre 2019
Presence of T cells directed against CD20-derived peptides in healthy individuals and lymphoma patients.
Cancer immunology, immunotherapy : CII   07 septembre 2019
HLA-DRB3/4/5 mismatches are associated with increased risk of acute GVHD in 10/10 matched unrelated donor hematopoietic cell transplantation.
American journal of hematology   04 mai 2018
HLA coding in ProMISe: Guidelines from the Francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC).
Bulletin du cancer   08 novembre 2017